Invention Grant
- Patent Title: OxMIF as a diagnostic marker
-
Application No.: US14350186Application Date: 2012-10-04
-
Publication No.: US09958456B2Publication Date: 2018-05-01
- Inventor: Michael Thiele , Randolf J. Kerschbaumer , Dirk Voelkel , Patrice Douillard , Friedrich Scheiflinger
- Applicant: Baxalta GmbH , Baxalta Incorporated
- Applicant Address: US IL Bannockburn CH Zug
- Assignee: Baxalta Incorporated,Baxalta GmbH
- Current Assignee: Baxalta Incorporated,Baxalta GmbH
- Current Assignee Address: US IL Bannockburn CH Zug
- Agency: Morgan, Lewis & Bockius LLP
- International Application: PCT/EP2012/069598 WO 20121004
- International Announcement: WO2013/050453 WO 20130411
- Main IPC: G01N33/68
- IPC: G01N33/68 ; C07K16/24
Abstract:
The present invention pertains to the recognition that a specific oxMIF form of MIF is useful as a diagnostic marker in (MIF-related) diseases, in particular for example monitoring of disease progression. The present invention also pertains to the respective use of a diagnostic kit and a respective diagnostic assay and pertains to advantageous respective antibodies.
Public/Granted literature
- US20140248638A1 OXMIF AS A DIAGNOSTIC MARKER Public/Granted day:2014-09-04
Information query
IPC分类:
